| DR REDDYS LABS ADR/1 IR 5 |
| USA |
| Gesundheit |
| US2561352038 / 659157 |
| RDDA (Frankfurt) / RDY (NYSE) |
| FRA:RDDA, ETR:RDDA, RDDA:GR, NYSE:RDY |
| - |
| http://www.drreddys.com/ |
|
Dr. Reddy's Laboratories Ltd. is a prominent pharmaceutical company, engaged in the research, development, manufacturing, and marketing of a wide array of generic medicines, active pharmaceutical ingredients (APIs), and biosimilars. Founded in 1984, ..
>Volltext.. |
| 9396.32 Mio. EUR |
| 9285.79 Mio. EUR |
| 3437.98 Mio. EUR |
| - |
| 563.17 Mio. EUR |
| 0.68 EUR |
| 652.84 Mio. EUR |
| 179.83 Mio. EUR |
| - |
| 0.52 |
| 6.61% |
| 1.51% |
| 0.08 EUR |
| 0.53% |
| 0.53% |
| 25.07.25 - 0.07849413€ 30.07.24 - 0.016341638€ >weitere anzeigen... |
| - |
| DR. REDDYS, REDDYS, REDDY S, REDDY'S |
| 05.04.26 |
|